CI
CME icon

Conning Inc’s CME Group CME Stock Holding History

Conning Inc’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34M Sell
115,274
-9,086
-7% -$2.7M 1.13% 48
2025
Q4 		$34M Sell
124,360
-2,148
-2% -$584K 1.14% 21
2025
Q3 		$34.2M Buy
126,508
+2,463
+2% +$670K 1.14% 29
2025
Q2 		$34.2M Sell
124,045
-15,910
-11% -$4.33M 1.17% 41
2025
Q1 		$37.1M Sell
139,955
-14,611
-9% -$3.6M 1.3% 13
2024
Q4 		$35.9M Sell
154,566
-19,400
-11% -$4.46M 1.26% 28
2024
Q3 		$38.4M Sell
173,966
-2,430
-1% -$503K 1.27% 35
2024
Q2 		$34.6M Buy
176,396
+5,161
+3% +$1.07M 1.25% 42
2024
Q1 		$36.8M Buy
171,235
+20,295
+13% +$4.26M 1.21% 44
2023
Q4 		$31.7M Sell
150,940
-22,026
-13% -$4.7M 1.1% 49
2023
Q3 		$34.6M Sell
172,966
-18,245
-10% -$3.63M 1.26% 21
2023
Q2 		$35.4M Sell
191,211
-1,872
-1% -$346K 1.18% 40
2023
Q1 		$36.9M Sell
193,083
-7,266
-4% -$1.31M 1.23% 29
2022
Q4 		$33.6M Buy
200,349
+24,024
+14% +$4.17M 1.09% 48
2022
Q3 		$31.2M Sell
176,325
-44,198
-20% -$8.73M 1.11% 47
2022
Q2 		$45.1M Buy
220,523
+30,287
+16% +$6.42M 1.35% 12
2022
Q1 		$45.2M Buy
190,236
+186,915
+5,628% +$43.9M 1.23% 27
2021
Q4 		$759K Buy
3,321
+137
+4% +$30.1K 0.02% 209
2021
Q3 		$616K Sell
3,184
-779
-20% -$158K 0.02% 234
2021
Q2 		$843K Sell
3,963
-420
-10% -$88.7K 0.02% 207
2021
Q1 		$895K Sell
4,383
-440
-9% -$86.7K 0.03% 202
2020
Q4 		$878K Sell
4,823
-331
-6% -$56.3K 0.03% 211
2020
Q3 		$862K Buy
5,154
+79
+2% +$13.3K 0.03% 204
2020
Q2 		$825K Buy
5,075
+35
+0.7% +$6.27K 0.03% 201
2020
Q1 		$871K Sell
5,040
-80
-2% -$15.9K 0.04% 189
2019
Q4 		$1.03M Buy
5,120
+50
+1% +$10.3K 0.03% 196
2019
Q3 		$1.07M Sell
5,070
-310
-6% -$64.8K 0.04% 208
2019
Q2 		$1.04M Sell
5,380
-895
-14% -$165K 0.03% 214
2019
Q1 		$1.03M Buy
6,275
+80
+1% +$14.1K 0.03% 241
2018
Q4 		$1.17M Sell
6,195
-630
-9% -$116K 0.04% 220
2018
Q3 		$1.16M Sell
6,825
-290
-4% -$48.8K 0.03% 249
2018
Q2 		$1.17M Sell
7,115
-280
-4% -$45.7K 0.04% 263
2018
Q1 		$1.2M Sell
7,395
-8,640
-54% -$1.38M 0.04% 250
2017
Q4 		$2.34M Buy
16,035
+8,530
+114% +$1.21M 0.08% 163
2017
Q3 		$1.02M Sell
7,505
-20
-0.3% -$2.53K 0.03% 270
2017
Q2 		$942K Sell
7,525
-115
-2% -$13.8K 0.03% 283
2017
Q1 		$908K Sell
7,640
-30
-0.4% -$3.61K 0.03% 284
2016
Q4 		$885K Sell
7,670
-840
-10% -$93.5K 0.04% 280
2016
Q3 		$889K Buy
8,510
+490
+6% +$51.2K 0.04% 282
2016
Q2 		$781K Sell
8,020
-222,155
-97% -$21M 0.03% 293
2016
Q1 		$22.1M Buy
230,175
+12,384
+6% +$1.13M 0.93% 50
2015
Q4 		$19.7M Sell
217,791
-8,459
-4% -$796K 0.84% 50
2015
Q3 		$21M Sell
226,250
-20,100
-8% -$1.91M 0.92% 50
2015
Q2 		$22.9M Sell
246,350
-7,950
-3% -$742K 0.94% 47
2015
Q1 		$24.1M Buy
254,300
+17,476
+7% +$1.62M 1.02% 49
2014
Q4 		$21M Sell
236,824
-5,392
-2% -$457K 1.02% 41
2014
Q3 		$19.4M Sell
242,216
-1,145
-0.5% -$86.3K 1.01% 43
2014
Q2 		$17.3M Buy
243,361
+26,895
+12% +$1.89M 0.92% 53
2014
Q1 		$16M Buy
216,466
+25,072
+13% +$1.89M 0.94% 50
2013
Q4 		$15M Buy
191,394
+34,751
+22% +$2.72M 0.93% 52
2013
Q3 		$11.6M Sell
156,643
-6,186
-4% -$456K 0.89% 50
2013
Q2 		$12.4M Buy
+162,829
New +$10.7M 1.02% 31

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Conning Inc's CME Position: Q1 2026 in Review

Conning Inc reduced its CME Group (CME) stake by 7.3% in Q1 2026, selling an estimated $2.7M and leaving 115,274 shares worth $34M. The position accounts for 1.13% of the portfolio, ranked #48.

Conning Inc first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $45.2M in Q1 2022. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Conning Inc held 115,274 shares of CME Group worth $34M as of Q1 2026.
  • Conning Inc sold 9,086 CME Group shares in Q1 2026, an estimated $2.7M.
  • CME Group made up 1.13% of Conning Inc's portfolio in Q1 2026, its #48 holding.
  • Conning Inc first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • Conning Inc's CME Group position peaked at $45.2M in Q1 2022.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Conning Inc's 13F filing for Q1 2026, filed 30 Apr 2026.